JPS6150925B2 - - Google Patents

Info

Publication number
JPS6150925B2
JPS6150925B2 JP54174018A JP17401879A JPS6150925B2 JP S6150925 B2 JPS6150925 B2 JP S6150925B2 JP 54174018 A JP54174018 A JP 54174018A JP 17401879 A JP17401879 A JP 17401879A JP S6150925 B2 JPS6150925 B2 JP S6150925B2
Authority
JP
Japan
Prior art keywords
group
pyridine
tetrahydro
thieno
compound
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
JP54174018A
Other languages
English (en)
Japanese (ja)
Other versions
JPS5592318A (en
Inventor
Furansowa Anri Buranshaaru Jan
Panaku Edowaaru
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Parcor SARL
Original Assignee
Parcor SARL
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Parcor SARL filed Critical Parcor SARL
Publication of JPS5592318A publication Critical patent/JPS5592318A/ja
Publication of JPS6150925B2 publication Critical patent/JPS6150925B2/ja
Granted legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Neurology (AREA)
  • Diabetes (AREA)
  • Biomedical Technology (AREA)
  • Hematology (AREA)
  • Neurosurgery (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Pyridine Compounds (AREA)
JP17401879A 1978-12-29 1979-12-29 Thrombosis remedy Granted JPS5592318A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB7850360A GB2038178B (en) 1978-12-29 1978-12-29 Antithrombotic therapeutic compsition

Publications (2)

Publication Number Publication Date
JPS5592318A JPS5592318A (en) 1980-07-12
JPS6150925B2 true JPS6150925B2 (fr) 1986-11-06

Family

ID=10502011

Family Applications (1)

Application Number Title Priority Date Filing Date
JP17401879A Granted JPS5592318A (en) 1978-12-29 1979-12-29 Thrombosis remedy

Country Status (8)

Country Link
JP (1) JPS5592318A (fr)
BE (1) BE880885A (fr)
DE (1) DE2951669C2 (fr)
FR (1) FR2445142A1 (fr)
GB (1) GB2038178B (fr)
IE (1) IE48883B1 (fr)
IL (1) IL58816A (fr)
IT (1) IT1162497B (fr)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FI101150B (fi) * 1991-09-09 1998-04-30 Sankyo Co Menetelmä lääkeaineina käyttökelpoisten tetrahydrotienopyridiinin johd annaisten valmistamiseksi
AU750122C (en) * 1998-06-17 2003-02-27 Bristol-Myers Squibb Company Preventing cerebral infarction through administration of ADP-receptor antiplatelet and antihypertensive drugs in combination

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2215948B1 (fr) * 1973-02-01 1976-05-14 Centre Etd Ind Pharma
FR2307538A1 (fr) * 1975-04-18 1976-11-12 Centre Etd Ind Pharma Nouveau medicament anti-agregant plaquettaire

Also Published As

Publication number Publication date
IL58816A (en) 1982-07-30
DE2951669C2 (de) 1985-08-22
IL58816A0 (en) 1980-02-29
IE48883B1 (en) 1985-06-12
GB2038178A (en) 1980-07-23
FR2445142B1 (fr) 1981-09-11
BE880885A (fr) 1980-06-27
IT1162497B (it) 1987-04-01
IE792280L (en) 1980-06-29
DE2951669A1 (de) 1980-07-17
JPS5592318A (en) 1980-07-12
FR2445142A1 (fr) 1980-07-25
IT7951222A0 (it) 1979-12-28
GB2038178B (en) 1983-03-09

Similar Documents

Publication Publication Date Title
RU2095062C1 (ru) Блокатор синдрома отмены, являющегося результатом привыкания к чрезмерному потреблению лекарств или веществ, вызывающих привыкание, фармакологическая композиция на его основе и способ облегчения или предотвращения синдрома отмены
CN110785170A (zh) 脂肪细胞的治疗
JPH01254627A (ja) 医薬組成物
EP1123702A1 (fr) Analgesiques
JPH05132430A (ja) 薬物従属症及び禁断症状の治療に関するグリシン／ｎｍｄａレセプターリガンドの用法
US5705506A (en) Pharmaceutical compositions of alkylsulphonamides 5HT1 agonists for rectal administration
SK15472001A3 (sk) Použitie saredutantu a jeho farmaceuticky prijateľných solí na prípravu liečiva použiteľného na liečenie alebo prevenciu porúch nálady, porúch adaptácie alebo stavov úzkosti a depresie
EA015483B1 (ru) ПРИМЕНЕНИЕ ИНГИБИТОРА p38 КИНАЗЫ ДЛЯ ЛЕЧЕНИЯ ПСИХИАТРИЧЕСКИХ РАССТРОЙСТВ
JPH02138214A (ja) 不安を治療する方法
JPH05509293A (ja) 不整脈および発作の治療における５―ｈｔ４受容体拮抗剤の使用
JPS6150925B2 (fr)
CN115768433A (zh) 含有司培前列素的医药制剂
JPS6150926B2 (fr)
JP2005506369A (ja) 肺高血圧症を予防または治療するのに用いられる医薬の製造のためのイルベサルタンの使用
PL206268B1 (pl) Kompozycja przeciwbólowa i/lub przeciwzapalna oraz jej zastosowanie
US4464377A (en) Anti-thrombotic therapeutic compositions
HU228775B1 (hu) 6-(Dimetilamino-metil)-1-fenil-ciklohexán vegyületek felhasználása vizeletinkontinencia kezelésére és ezeket tartalmazó gyógyszerkészítmények
SK287536B6 (sk) Použitie substituovaných zlúčenín 6-dimetylaminometyl-1-fenyl- cyklohexanónu na terapiu inkontinencie moču
JP2007516165A (ja) 神経防護作用医薬組成物の製造におけるビシクロ［２．２．１］ヘプタン誘導体の使用
MX2010006520A (es) Metodo y composicion para el tratamiento de una condicion mediada por alfa-adrenoceptor.
TW201808285A (zh) 焦慮症處置用組成物及處置方法
JPS6019893B2 (ja) 抗潰瘍剤
US5232686A (en) Gastroprotective pharmaceutical preparations containing n-benzyl-n-((1s,5s)-6,6-dimethylbicyclo(3,1,1)-hept-2-ylethoxy-ethyl)-morpholinium salts
SK286984B6 (sk) Použitie derivátov 3(2H)-pyridazinónu na prípravu liečiva na liečenie funkčnej poruchy erekcie
CA1147659A (fr) Composes therapeutiques pour prevenir les thromboses